Patents by Inventor Raviraja Neelavar Seetharam

Raviraja Neelavar Seetharam has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10865385
    Abstract: The present invention discloses a method of isolation, pooling and further culturing of Mesenchymal Stem cells (MSC) for clinical application. Present invention also discloses the method of establishing Master Cell bank, followed by Working Cell Bank from which the final therapeutic composition referred to as Investigational Product/Investigational Medicinal Product comprising of allogenic bone marrow-derived MSC is formulated for clinical applications.
    Type: Grant
    Filed: February 17, 2015
    Date of Patent: December 15, 2020
    Assignee: Stempeutics Research Pvt. Ltd.
    Inventors: Rakhi Pal, Pawan Kumar Gupta, Prasanna Kumar Kemburu, Jyothi Prasanna, Satish Totey, Raviraja Neelavar Seetharam, Umesh Baikunje Golithadka, Anish Sen Majumdar
  • Publication number: 20160206550
    Abstract: The present disclosure relates to a conditioned medium (CM) enriched with bioactive factor, its composition and the method of producing the CM. The method of obtaining the desired quantity of bioactive factors in conditioned medium comprises of pooling bone marrow derived mesenchymal stromal/stem cells, culturing the pooled cell and subjecting the cell culture to a cell feeding schedule at specified confluency and collecting the potent conditioned medium rich in bioactive factors at specific passage/time period. The method further aims at maximizing the probability of generating a conditioned medium with reduced biological variability and comprising large number of bioactive factors having specific biological function/property. The disclosure also relates to composition and formulation of the conditioned medium and their use in cosmetic and therapeutic areas.
    Type: Application
    Filed: June 18, 2014
    Publication date: July 21, 2016
    Applicant: STEMPEUTICS RESEARCH PVT. LTD.
    Inventors: Sudha BALASUBRAMANIAN, Swathi SUNDAR RAJ, Charan THEJ, Ramesh RAMCHANDRA BHONDE, Raviraja NEELAVAR SEETHARAM, Anish SEN MAJUMDAR
  • Publication number: 20150159138
    Abstract: The present invention discloses a method of isolation, pooling and further culturing of Mesenchymal Stem cells (MSC) for clinical application. Present invention also discloses the method of establishing Master Cell bank, followed by Working Cell Bank from which the final therapeutic composition referred to as Investigational Product/Investigational Medicinal Product comprising of allogenic bone marrow-derived MSC is formulated for clinical applications.
    Type: Application
    Filed: February 17, 2015
    Publication date: June 11, 2015
    Inventors: Rakhi PAL, Pawan Kumar GUPTA, Prasanna Kumar KEMBURU, Jyothi PRASANNA, Satish TOTEY, Raviraja Neelavar SEETHARAM, Umesh Baikunje GOLITHADKA, Anish Sen MAJUMDAR
  • Patent number: 8956862
    Abstract: The present invention discloses a method of isolation, pooling and further culturing of Mesenchymal Stem cells (MSC) for clinical application. Present invention also discloses the method of establishing Master Cell bank, followed by Working Cell Bank from which the final therapeutic composition referred to as Investigational Product/Investigational Medicinal Product comprising of allogenic bone marrow-derived MSC is formulated for clinical applications.
    Type: Grant
    Filed: November 25, 2010
    Date of Patent: February 17, 2015
    Assignee: Stempeutics Research Pvt. Ltd.
    Inventors: Rakhi Pal, Pawan Kumar Gupta, Prasanna Kumar Kemburu, Jyothi Prasanna, Satish Totey, Raviraja Neelavar Seetharam, Umesh Baikunje Golithadka, Anish Sen Majumdar
  • Publication number: 20110229965
    Abstract: The present invention discloses a method of isolation, pooling and further culturing of Mesenchymal Stem cells (MSC) for clinical application. Present invention also discloses the method of establishing Master Cell bank, followed by Working Cell Bank from which the final therapeutic composition referred to as Investigational Product/Investigational Medicinal Product comprising of allogenic bone marrow-derived MSC is formulated for clinical applications.
    Type: Application
    Filed: November 25, 2010
    Publication date: September 22, 2011
    Inventors: Rakhi Pal, Pawan Kumar Gupta, Prasanna Kumar Kemburu, Joyothi Prasanna, Satish Totey, Raviraja Neelavar Seetharam, Umesh Baikunje Golithadka, Anish Sen Majumdar